Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| French Interregional Group of Clinical Research and Innovation | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of the research is to evaluate the effectiveness of virtual reality on the anxiety of patients with suspected endometriosis in gynecological consultation.
Indeed, several studies prove that patients in this situation are anxious. We would like to offer help in reducing anxiety in this case by means of digital therapy.
As part of this study, the equipment used will be "Bliss DTX". This is a non-drug digital therapy (digital therapeutics) already used in various hospital departments.
Bliss DTX immerses patients in sound and image programs scientifically developed for their effect on pain and anxiety, mobilizing their abilities and placing them in an altered state of consciousness. Bliss DTX software is delivered to patients via a dedicated video headset (virtual reality) and audio headset, as part of an integrated solution.
Conduct of the study:
The patient will be taken care of on the day of the consultation by a clinical research nurse. It will be installed in a reception room in the consultation room. The nurse will give him a questionnaire on anxiety to complete before the consultation.
A draw will be carried out with two options:
A telephone call will be made 6 months after the consultation to collect post-consultation information.
Duration :
Duration of 6 months on 46 patients followed for 18 months. Expected benefits
Possible side effects:
No particular risks or constraints, however, a virtual reality headset can cause symptoms such as: nausea, dizziness, sweating, paleness, balance disorders grouped under the term "cybernetosis" as well as epileptic seizures in people. subjects predisposed to convulsions.
Title :
ENDOREV: A solution to reduce anxiety during gynecological consultations in patients with suspected endometriosis?
Description of the study :
Single-center, randomized, controlled, open-label interventional study on two parallel groups Study composed of 46 patients randomized into two groups A and B with a ratio of 1:1 Experimental Group A: The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes Group B control: The patient will be seated and wait for the doctor to arrive (no material) The duration of inclusion is 18 months and individual participation is 6 months, that is to say 24 months for the entire study.
Completion of the questionnaire (IASTA Y-1) for both groups before the consultation and data collection.
Filling of the CRF in consultation by the doctor Completion of the questionnaire (IASTA Y-1) for both arms after the consultation and data collection Telephone call at 6 months with data collection on compliance with endometriosis monitoring
Objectives :
Primary objectives :
• Evaluate the effectiveness of virtual reality on anxiety in women with suspected endometriosis during the gynecological consultation.
Secondary objectives :
Hypothesis :
Inclusion criteria :
Exclusion criteria:
Place of the study :
Intercommunal Hospital Center of Poissy Saint-Germain-En-Laye
Contact details :
Intercommunal Hospital Center of Poissy Saint-Germain-En-Laye Address: 10 rue du Champ Gaillard, 78300 Poissy Tel: +33139274581 Email: elise.lunelli@ght-yvelinesnord.fr
Speakers :
Funding :
GIRCI IDF and ARS IDF funding as part of the call for projects " Appel à projets recherche en soins (APRESO) "2024
Calendar :
Primary submission : 11/09/24 Secondary submission :26/09/24
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Experimental | Experimental Group A: The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes |
|
| group B | No Intervention | Group B control: The patient will be installed in a reception room and will be seated and wait for the doctor to arrive (no material) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual reality headset Bliss DTX | Device | The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants showing a reduction in post-consultation anxiety | Pre-consultation until post-consultation |
Not provided
Not provided
Inclusion Criteria:
• Patient between 18 and 45 years old
Exclusion Criteria:
• Patient with a history of major pelvic surgery for endometriosis
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Elise LUNELLI | Contact | +33139274581 | elise.lunelli@ght-yvelinesnord.fr |
| Name | Affiliation | Role |
|---|---|---|
| Arnaud FAUCONNIER, PROFESSOR | Pr FAUCONNIER | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Poissy-Saint Germain Hospital | Recruiting | Poissy | 78300 | France |
In accordance with the provisions of the law relating to data processing, files and freedoms (law 78-17 of January 6, 1978 as amended) and the general data protection regulation (EU) 2016/679 (GDPR), the patient has a right to object at any time to the processing of their data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004715 | Endometriosis |
| ID | Term |
|---|---|
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Single-center, randomized, controlled, open-label interventional study on two parallel groups
Not provided
Not provided
Not provided
Not provided
| D000091662 | Genital Diseases |